Iovance Biotherapeutics, Inc.
Clinical trials sponsored by Iovance Biotherapeutics, Inc., explained in plain language.
-
Immune cells from your own tumor could fight melanoma
Disease control CompletedThis study tested a new treatment for people with advanced melanoma that has spread or cannot be removed by surgery. The treatment uses a patient's own immune cells, called tumor-infiltrating lymphocytes (TILs), which are grown in a lab and then infused back into the patient. The…
Phase: PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 10:59 UTC
-
Experimental cell therapy targets hard-to-treat blood cancers
Disease control CompletedThis early-phase trial tested a new cell therapy called IOV-2001 in 7 people whose chronic lymphocytic leukemia or small lymphocytic lymphoma had stopped responding to standard treatments like ibrutinib. The therapy uses the patient's own immune cells, which are collected, proces…
Phase: PHASE1 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated May 18, 2026 12:04 UTC